Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Colloid Interface Sci. 2018 Sep 22;535:133–148. doi: 10.1016/j.jcis.2018.09.072

Figure 2. Intracellular uptake of TAP NPs in breast cancer MDA-MB-231 cells.

Figure 2.

A) Cellular uptake of Coumarin 6 uptake in breast cancer MDA-MB-231 cells were confirmed by fluorescence microscopy an EVOS® 214 FL Imaging System, in a time dependent manner with dye loaded nanoparticles. B) Intracellular uptake of TAP NPs by LC-MS/MS in MDA-MB-231 after treatment with PTX and TAP NPs for 2, 4 and 6 hours. Cells were treated with PTX and TAP NPs (equivalent to 500 ng of PTX) resulting in 95.52% of drug internalization by TAP NPs in 6 hours in contrast to only 57.19% by native drug PTX for the same time. Data presented as mean ± standard error of the mean (n = 3). A Liquid chromatography–tandem mass spectrometry (LC-MS/MS) (Shimadzu Corporation, Kyoto, Japan) connected to Triple Quad 5500 tandem mass spectrometer (AB SCIEX, Framingham, MA, at a flow rate of 0.8 mL/min was used to determine drug concentration(s) in cells.